Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19565353 | 0.84 | CNR1 (0.39) | PRKCAALDH1A1CNR1CNR2 | |
| SCHEMBL22112602 | 0.83 | PRKCA (0.33) | PRKCAALDH1A1CNR1CNR2 | |
| SCHEMBL19565193 | 0.79 | PRKCA (0.36) | PRKCA | |
| SCHEMBL15267750 | 0.67 | ALDH1A1 (0.37) | ALDH1A1CNR1CNR2 | |
| SCHEMBL19565378 | 0.66 | TSHR (0.37) | PRKCAALDH1A1CNR1CNR2 | |
| SCHEMBL11890269 | 0.66 | TSHR (0.44) | PRKCAALDH1A1CNR1CNR2 | |
| SCHEMBL18416046 | 0.65 | USP2 (0.33) | ALDH1A1CNR1CNR2 | |
| SCHEMBL6861822 | 0.65 | TSHR (0.35) | ALDH1A1CNR1CNR2 | |
| SCHEMBL337832 | 0.65 | — | — | |
| SCHEMBL8506082 | 0.64 | TDP1 (0.47) | PRKCAALDH1A1CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11332445-B2 | Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2022-05-17 | — | — | US | disclosed |
| US-20200190037-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2020-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200190037-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | ACR, HACD3, FCGR3B | PRKCA 3515/4885ALDH1A1 1557/4885CNR1 2134/4885 |
| US-11332445-B2 | Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission | ACR, HACD3, FCGR3B | PRKCA 3515/4885ALDH1A1 1557/4885CNR1 2134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.